Pimecrolimus

Chemical formula: C₄₃H₆₈ClNO₁₁  Molecular mass: 810.46 g/mol  PubChem compound: 6509979

Therapeutic indications

Pimecrolimus is indicated for:

Mild or moderate atopic dermatitis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Treatment of patients aged 2 years and over with mild or moderate atopic dermatitis where treatment with topical corticosteroids is either inadvisable or not possible. This may include:

  • Intolerance to topical corticosteroids.
  • Lack of effect of topical corticosteroids.
  • Use on the face and neck where prolonged intermittent treatment with topical corticosteroids may be inappropriate.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: ELIDEL Cream
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈